JP5996633B2 - 酸型カルボキシメチルセルロースを含む崩壊性粒子組成物の製造方法、並びに、該組成物及び該組成物を含む口腔内崩壊錠剤 - Google Patents

酸型カルボキシメチルセルロースを含む崩壊性粒子組成物の製造方法、並びに、該組成物及び該組成物を含む口腔内崩壊錠剤 Download PDF

Info

Publication number
JP5996633B2
JP5996633B2 JP2014507973A JP2014507973A JP5996633B2 JP 5996633 B2 JP5996633 B2 JP 5996633B2 JP 2014507973 A JP2014507973 A JP 2014507973A JP 2014507973 A JP2014507973 A JP 2014507973A JP 5996633 B2 JP5996633 B2 JP 5996633B2
Authority
JP
Japan
Prior art keywords
wet granulation
granulation step
component
components
granulated product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014507973A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2013146917A1 (ja
Inventor
隆弘 平邑
隆弘 平邑
聖 以倉
聖 以倉
左枝 石川
左枝 石川
智仁 岡林
智仁 岡林
尚弘 橋川
尚弘 橋川
森田　哲郎
哲郎 森田
君子 池田
君子 池田
晴香 若山
晴香 若山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daicel Corp
Nichirin Chemical Industries Ltd
Original Assignee
Daicel Corp
Nichirin Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49260166&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5996633(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daicel Corp, Nichirin Chemical Industries Ltd filed Critical Daicel Corp
Publication of JPWO2013146917A1 publication Critical patent/JPWO2013146917A1/ja
Application granted granted Critical
Publication of JP5996633B2 publication Critical patent/JP5996633B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
JP2014507973A 2012-03-29 2013-03-27 酸型カルボキシメチルセルロースを含む崩壊性粒子組成物の製造方法、並びに、該組成物及び該組成物を含む口腔内崩壊錠剤 Active JP5996633B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP2012075832 2012-03-29
JP2012075832 2012-03-29
JP2012206895 2012-09-20
JP2012206896 2012-09-20
JP2012206896 2012-09-20
JP2012206895 2012-09-20
JP2012275942 2012-12-18
JP2012275942 2012-12-18
PCT/JP2013/059083 WO2013146917A1 (ja) 2012-03-29 2013-03-27 酸型カルボキシメチルセルロースを含む崩壊性粒子組成物の製造方法、並びに、該組成物及び該組成物を含む口腔内崩壊錠剤

Publications (2)

Publication Number Publication Date
JPWO2013146917A1 JPWO2013146917A1 (ja) 2015-12-14
JP5996633B2 true JP5996633B2 (ja) 2016-09-21

Family

ID=49260166

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014507973A Active JP5996633B2 (ja) 2012-03-29 2013-03-27 酸型カルボキシメチルセルロースを含む崩壊性粒子組成物の製造方法、並びに、該組成物及び該組成物を含む口腔内崩壊錠剤

Country Status (8)

Country Link
US (2) US20150174075A2 (enExample)
EP (1) EP2832350B1 (enExample)
JP (1) JP5996633B2 (enExample)
KR (1) KR101707938B1 (enExample)
CN (1) CN104080443B (enExample)
IN (1) IN2014DN07797A (enExample)
TW (1) TWI610691B (enExample)
WO (1) WO2013146917A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2015005241A1 (ja) * 2013-07-06 2017-03-02 株式会社ダイセル 超速崩壊錠剤及びその製造方法

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014DN07797A (enExample) 2012-03-29 2015-05-15 Daicel Corp
JP6230539B2 (ja) 2012-09-20 2017-11-15 株式会社ダイセル 酸型カルボキシメチルセルロース及び結晶セルロースを含む崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤
JP6302921B2 (ja) * 2013-09-27 2018-03-28 株式会社ダイセル 崩壊性粒子組成物を含む口腔内崩壊錠剤
JP6476122B2 (ja) * 2013-09-27 2019-02-27 株式会社ダイセル 二段階の湿式造粒工程で製造される崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤
JP2017036214A (ja) * 2013-12-10 2017-02-16 株式会社ダイセル 炭酸塩を含む口腔内崩壊錠剤用組成物及び口腔内崩壊錠剤
JP6566934B2 (ja) * 2014-04-21 2019-08-28 株式会社ダイセル 微小繊維状セルロースを含む崩壊性粒子組成物
JP2017226600A (ja) * 2014-10-16 2017-12-28 株式会社ダイセル 超速崩壊錠剤
AU2015351685B2 (en) 2014-11-24 2020-07-16 Daicel Corporation Disintegrative particle composition including pulverized lactose or granulated lactose
WO2016098459A1 (ja) * 2014-12-17 2016-06-23 株式会社ダイセル 遅延崩壊性粒子組成物
EP3238712B1 (en) * 2014-12-25 2023-11-01 Daicel Corporation Very rapidly disintegrating tablet, and method for producing same
JP5897196B1 (ja) * 2015-10-05 2016-03-30 大同化成工業株式会社 糖又は糖アルコール、膨潤型結合剤、崩壊剤及び高吸収性賦形剤を含む複合化造粒物及びその製造方法
JP6606287B2 (ja) 2016-07-27 2019-11-13 沢井製薬株式会社 口腔内崩壊錠添加用組成物
JP6651638B2 (ja) 2016-09-06 2020-02-19 沢井製薬株式会社 口腔内崩壊錠添加用組成物
EP3827673A4 (en) * 2018-07-25 2022-05-04 Daicel Corporation PARTICULAR DISCOMPOSITION COMPOSITION CONTAINING MICROFIBROUS CELLULOSE BUT CONTAINING NO EXCIPIENT
JP7360460B2 (ja) * 2019-06-07 2023-10-12 あゆみ製薬株式会社 口腔内崩壊錠及びその製造方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851453A (en) * 1954-08-09 1958-09-09 Smith Kline French Lab Cellulose derivative product, compositions comprising the same and their preparation
JPH10182436A (ja) 1996-10-31 1998-07-07 Takeda Chem Ind Ltd 固形医薬製剤
JP2000273039A (ja) 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
EP1329217A4 (en) 2000-10-06 2007-04-04 Takeda Pharmaceutical Solid preparations
JP4284017B2 (ja) * 2000-10-06 2009-06-24 武田薬品工業株式会社 固形製剤
JP4551627B2 (ja) 2003-02-28 2010-09-29 東和薬品株式会社 口腔内崩壊錠剤の製造方法
JP4505859B2 (ja) 2003-08-08 2010-07-21 味の素株式会社 ナテグリニド含有製剤
KR20130016386A (ko) * 2005-08-10 2013-02-14 시오노기세이야쿠가부시키가이샤 구강내 붕괴 정제
JP5123517B2 (ja) 2005-11-14 2013-01-23 帝人ファーマ株式会社 アンブロキソール口腔内速崩性錠剤
US8298576B2 (en) * 2006-11-17 2012-10-30 Supernus Pharmaceuticals, Inc. Sustained-release formulations of topiramate
JP5766899B2 (ja) * 2007-04-11 2015-08-19 ニプロ株式会社 口腔内崩壊剤及びその製造方法
JP2008285434A (ja) 2007-05-16 2008-11-27 Taisho Pharm Ind Ltd 口腔内速崩壊錠
CN101707930B (zh) 2007-06-06 2013-10-30 巴斯夫欧洲公司 用于制备快速崩解的片剂的药物配制剂
US20110053942A1 (en) * 2008-02-13 2011-03-03 Dainippon Sumitomo Pharma Co., Ltd. Orally disintegrating tablets
EP2368544A4 (en) * 2008-11-25 2012-08-15 Mitsubishi Tanabe Pharma Corp RAPID ORAL DELETING TABLET, AND PROCESS FOR PRODUCING THE SAME
WO2011019045A1 (ja) 2009-08-11 2011-02-17 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
JP4920798B2 (ja) 2009-08-11 2012-04-18 大日本住友製薬株式会社 ２種以上の粒子を含有する口腔内速崩壊錠
US20110150989A1 (en) 2009-12-22 2011-06-23 Mallinkckrodt Inc. Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
US9198861B2 (en) * 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
JP6073543B2 (ja) 2010-07-08 2017-02-01 沢井製薬株式会社 ロラタジン含有口腔内崩壊錠の製造方法
JP5630902B2 (ja) * 2010-08-26 2014-11-26 沢井製薬株式会社 ゾルピデム酒石酸塩含有口腔内崩壊錠の製造方法
JP6245677B2 (ja) 2012-01-20 2017-12-13 ニプロ株式会社 口腔内崩壊錠
IN2014DN07797A (enExample) 2012-03-29 2015-05-15 Daicel Corp
JP6230539B2 (ja) 2012-09-20 2017-11-15 株式会社ダイセル 酸型カルボキシメチルセルロース及び結晶セルロースを含む崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤
JP6476122B2 (ja) * 2013-09-27 2019-02-27 株式会社ダイセル 二段階の湿式造粒工程で製造される崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤
AU2015351685B2 (en) * 2014-11-24 2020-07-16 Daicel Corporation Disintegrative particle composition including pulverized lactose or granulated lactose
TWI690333B (zh) * 2015-06-29 2020-04-11 日商大賽璐股份有限公司 易服用性固態製劑（有核錠）之製造方法及易服用性固態製劑

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2015005241A1 (ja) * 2013-07-06 2017-03-02 株式会社ダイセル 超速崩壊錠剤及びその製造方法

Also Published As

Publication number Publication date
WO2013146917A1 (ja) 2013-10-03
KR20140144249A (ko) 2014-12-18
US12059501B2 (en) 2024-08-13
JPWO2013146917A1 (ja) 2015-12-14
US20150045452A1 (en) 2015-02-12
US20200038332A1 (en) 2020-02-06
TW201400145A (zh) 2014-01-01
CN104080443A (zh) 2014-10-01
CN104080443B (zh) 2017-12-12
EP2832350A1 (en) 2015-02-04
EP2832350A4 (en) 2015-11-18
TWI610691B (zh) 2018-01-11
IN2014DN07797A (enExample) 2015-05-15
KR101707938B1 (ko) 2017-02-17
EP2832350B1 (en) 2019-07-17
US20150174075A2 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
JP5996633B2 (ja) 酸型カルボキシメチルセルロースを含む崩壊性粒子組成物の製造方法、並びに、該組成物及び該組成物を含む口腔内崩壊錠剤
JP6230539B2 (ja) 酸型カルボキシメチルセルロース及び結晶セルロースを含む崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤
TWI644688B (zh) 含有崩解性粒子組成物之口腔內崩解錠劑之製造方法
JP6476122B2 (ja) 二段階の湿式造粒工程で製造される崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤
WO2015087823A1 (ja) 炭酸塩を含む口腔内崩壊錠剤用組成物及び口腔内崩壊錠剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150917

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160614

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160721

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160816

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160824

R150 Certificate of patent or registration of utility model

Ref document number: 5996633

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250